Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00761982

Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment.

Autologous Bone Marrow Stem Cells in Middle Cerebral Artery Acute Stroke Treatment

Sponsor: Hospital Universitario Central de Asturias

Conditions Infarction, Middle Cerebral Artery Stroke, Acute

Interventions Infusion on autologous CD34+ stem cells into middle cerebral artery

Updated 6 times since 2017 Last updated: Nov 27, 2011 Started: Sep 30, 2008 Primary completion: Aug 31, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Infarction, Middle Cerebral Artery and Stroke, Acute and is currently completed. Hospital Universitario Central de Asturias leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1_PHASE2

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitario Central de Asturias
Hospitales Universitarios Virgen del Rocío

Data source: Hospital Universitario Central de Asturias

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Oviedo, Spain
• Seville, Spain